BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Advanced BioNutrition Corporation Receives MdBio Grant To Commercialize Novel Microencapsulation Technology


10/19/2005 5:10:09 PM

COLUMBIA, Md.--(BUSINESS WIRE)--Feb. 24, 2004--Advanced BioNutrition Corp. (ABN), a leader in developing functional nutrition technology to improve animal health and human nutrition, announced that it has received a $200,000 award from MdBio for scaleup and commercialization of ABN's novel microencapsulation technology.

ABN's technology is designed to provide targeted delivery of probiotics and bioactive compounds to the site of activity in the guts of aquatic animals, using all GRAS (Generally Recognized As Safe) food-grade materials. Probiotics are "friendly" bacteria that prevent the growth of pathogenic bacteria and can alleviate the need for antibiotic treatment.

Beneficial bioactive compounds are normally destroyed in the harsh environment of the stomach before they reach the intestines, where they can prevent the growth of pathogenic bacteria. ABN's microencapsulation process protects these helpful bacteria and enables their release to targeted areas of the gastrointestinal tract.

ABN's microencapsulation technology provides a revolutionary new method to deliver easily degraded compounds such as vaccines, enzymes and other nutraceutical products in a bioactive form.

"We are very excited about the potential of this new technology to produce healthier and safer seafood products," said David J. Kyle, president and CEO of ABN. "Our novel microencapsulation technology could also enable the development of a new generation of probiotic products for human consumption."

Work under this project, titled "Commercial Production of Targeted Probiotic MicroCapsules for Aquatic Animals," will be conducted by ABN at its own laboratories, in conjunction with the Maryland Technology Enterprise Institute at the University of Maryland.

About MdBio

MdBio, Inc. is a private, non-profit corporation that offers a variety of programs to advance the commercial development of bioscience in Maryland.

About ABN

Advanced BioNutrition is a leader in developing functional nutrition technology to improve animal health and human nutrition. The company is headquartered in Columbia, MD. www.abn-corp.com.

--------------------------------------------------------------------------------
Contact:
Advanced BioNutrition Corp.
Al Cunniff, 410-730-8600

--------------------------------------------------------------------------------
Source: Advanced BioNutrition Corp.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES